CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...

A pioneering genetic treatment is saving lives where chemotherapy failed, offering new hope for children and adults with ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

Adult patients with an aggressive form of leukemia will be able to receive a breakthrough immunotherapy, which was invented ...

A major breakthrough in the treatment of an aggressive form of leukemia is bringing new hope to patients and it started in ...

Professor Waseem Qasim told LBC News the breakthrough demonstrates "the power and the potential" of emerging technologies ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the U.S. and Europe are diagnosed. For many, the road ahead is grim. Despite ...

A promising method of immunotherapy to treat children with relapsed acute lymphocytic leukemia (ALL) is opening at the University of Wisconsin Carbone Cancer Center and American Family Children’s ...

MONTREAL, Dec. 10, 2025 /CNW/ - Novartis Canada is pleased to announce that Scemblix ® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario's new Funding ...

WASHINGTON (AP) — Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek ...

It’s called ibrutinib, and it’s a potential breakthrough in treating chronic lymphocytic leukemia (CLL) that could leave patients with fewer side effects than chemotherapy. In research published in ...